<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">20392907</PMID><DateCompleted><Year>2010</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-660X</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>6</Issue><PubDate><Year>2010</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of clinical microbiology</Title><ISOAbbreviation>J Clin Microbiol</ISOAbbreviation></Journal><ArticleTitle>CagA and VacA polymorphisms are associated with distinct pathological features in Helicobacter pylori-infected adults with peptic ulcer and non-peptic ulcer disease.</ArticleTitle><Pagination><StartPage>2237</StartPage><EndPage>2239</EndPage><MedlinePgn>2237-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/JCM.00662-10</ELocationID><Abstract><AbstractText>Polymorphic variability in Helicobacter pylori factors CagA and VacA contributes to bacterial virulence. The presence of one CagA EPIYA-C site is an independent risk factor for gastroduodenal ulceration (odds ratio [OR], 4.647; 95% confidence interval [CI], 2.037 to 10.602), while the presence of the vacA i1 allele is a risk factor for increased activity (OR, 5.310; 95% CI, 2.295 to 12.287) and severity of gastritis (OR, 3.862; 95% CI, 1.728 to 8.632).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Panayotopoulou</LastName><ForeName>Effrosini G</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>Laboratory of Medical Microbiology, Hellenic Pasteur Institute, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sgouras</LastName><ForeName>Dionyssios N</ForeName><Initials>DN</Initials></Author><Author ValidYN="Y"><LastName>Papadakos</LastName><ForeName>Konstantinos S</ForeName><Initials>KS</Initials></Author><Author ValidYN="Y"><LastName>Petraki</LastName><ForeName>Kalliopi</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Breurec</LastName><ForeName>S&#xe9;bastien</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Michopoulos</LastName><ForeName>Spyros</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Mantzaris</LastName><ForeName>Gerassimos</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Papatheodoridis</LastName><ForeName>George</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Mentis</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Archimandritis</LastName><ForeName>Athanasios</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>FN561978</AccessionNumber><AccessionNumber>FN561979</AccessionNumber><AccessionNumber>FN561980</AccessionNumber><AccessionNumber>FN561981</AccessionNumber><AccessionNumber>FN561982</AccessionNumber><AccessionNumber>FN561983</AccessionNumber><AccessionNumber>FN561984</AccessionNumber><AccessionNumber>FN561985</AccessionNumber><AccessionNumber>FN561986</AccessionNumber><AccessionNumber>FN561987</AccessionNumber><AccessionNumber>FN561988</AccessionNumber><AccessionNumber>FN561989</AccessionNumber><AccessionNumber>FN561990</AccessionNumber><AccessionNumber>FN561991</AccessionNumber><AccessionNumber>FN561992</AccessionNumber><AccessionNumber>FN561993</AccessionNumber><AccessionNumber>FN561994</AccessionNumber><AccessionNumber>FN561995</AccessionNumber><AccessionNumber>FN561996</AccessionNumber><AccessionNumber>FN561997</AccessionNumber><AccessionNumber>FN561998</AccessionNumber><AccessionNumber>FN561999</AccessionNumber><AccessionNumber>FN562000</AccessionNumber><AccessionNumber>FN562001</AccessionNumber><AccessionNumber>FN562002</AccessionNumber><AccessionNumber>FN562003</AccessionNumber><AccessionNumber>FN562004</AccessionNumber><AccessionNumber>FN562005</AccessionNumber><AccessionNumber>FN562006</AccessionNumber><AccessionNumber>FN562007</AccessionNumber><AccessionNumber>FN562008</AccessionNumber><AccessionNumber>FN562009</AccessionNumber><AccessionNumber>FN562010</AccessionNumber><AccessionNumber>FN562011</AccessionNumber><AccessionNumber>FN562012</AccessionNumber><AccessionNumber>FN562013</AccessionNumber><AccessionNumber>FN562014</AccessionNumber><AccessionNumber>FN562015</AccessionNumber><AccessionNumber>FN562016</AccessionNumber><AccessionNumber>FN562017</AccessionNumber><AccessionNumber>FN562018</AccessionNumber><AccessionNumber>FN562019</AccessionNumber><AccessionNumber>FN562020</AccessionNumber><AccessionNumber>FN562021</AccessionNumber><AccessionNumber>FN562022</AccessionNumber><AccessionNumber>FN562023</AccessionNumber><AccessionNumber>FN562024</AccessionNumber><AccessionNumber>FN562025</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>04</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Microbiol</MedlineTA><NlmUniqueID>7505564</NlmUniqueID><ISSNLinking>0095-1137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000942">Antigens, Bacterial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004269">DNA, Bacterial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C074689">VacA protein, Helicobacter pylori</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037521">Virulence Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C080866">cagA protein, Helicobacter pylori</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000942" MajorTopicYN="N">Antigens, Bacterial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001426" MajorTopicYN="N">Bacterial Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004269" MajorTopicYN="N">DNA, Bacterial</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016481" MajorTopicYN="N">Helicobacter Infections</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016480" MajorTopicYN="N">Helicobacter pylori</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010437" MajorTopicYN="N">Peptic Ulcer</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="Y">Polymorphism, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037521" MajorTopicYN="N">Virulence Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2010</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20392907</ArticleId><ArticleId IdType="pmc">PMC2884518</ArticleId><ArticleId IdType="doi">10.1128/JCM.00662-10</ArticleId><ArticleId IdType="pii">JCM.00662-10</ArticleId></ArticleIdList><ReferenceList><Reference><Citation><b>Argent, R. H., M. Kidd, R. J. Owen, R. J. Thomas, M. C. Limb, and J. C. Atherton.</b> 2004. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 127<b>:</b>514-523.</Citation><ArticleIdList><ArticleId IdType="pubmed">15300584</ArticleId></ArticleIdList></Reference><Reference><Citation><b>Atherton, J. C.</b> 2006. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu. Rev. Pathol. 1<b>:</b>63-96.</Citation><ArticleIdList><ArticleId IdType="pubmed">18039108</ArticleId></ArticleIdList></Reference><Reference><Citation><b>Atherton, J. C., P. Cao, R. M. Peek, Jr., M. K. Tummuru, M. J. Blaser, and T. L. Cover.</b> 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270<b>:</b>17771-17777.</Citation><ArticleIdList><ArticleId IdType="pubmed">7629077</ArticleId></ArticleIdList></Reference><Reference><Citation><b>Azuma, T., S. Yamazaki, A. Yamakawa, M. Ohtani, A. Muramatsu, H. Suto, Y. Ito, M. Dojo, Y. Yamazaki, M. Kuriyama, Y. Keida, H. Higashi, and M. Hatakeyama.</b> 2004. Association between diversity in the Src homology 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J. Infect. Dis. 189<b>:</b>820-827.</Citation><ArticleIdList><ArticleId IdType="pubmed">14976598</ArticleId></ArticleIdList></Reference><Reference><Citation><b>Basso, D., C. F. Zambon, D. P. Letley, A. Stranges, A. Marchet, J. L. Rhead, S. Schiavon, G. Guariso, M. Ceroti, D. Nitti, M. Rugge, M. Plebani, and J. C. Atherton.</b> 2008. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 135<b>:</b>91-99.</Citation><ArticleIdList><ArticleId IdType="pubmed">18474244</ArticleId></ArticleIdList></Reference><Reference><Citation><b>Blaser, M. J., and J. C. Atherton.</b> 2004. Helicobacter pylori persistence: biology and disease. J. Clin. Invest. 113<b>:</b>321-333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC324548</ArticleId><ArticleId IdType="pubmed">14755326</ArticleId></ArticleIdList></Reference><Reference><Citation><b>Cover, T. L., and S. R. Blanke.</b> 2005. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat. Rev. Microbiol. 3<b>:</b>320-332.</Citation><ArticleIdList><ArticleId IdType="pubmed">15759043</ArticleId></ArticleIdList></Reference><Reference><Citation><b>Higashi, H., R. Tsutsumi, A. Fujita, S. Yamazaki, M. Asaka, T. Azuma, and M. Hatakeyama.</b> 2002. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc. Natl. Acad. Sci. U. S. A. 99<b>:</b>14428-14433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC137900</ArticleId><ArticleId IdType="pubmed">12391297</ArticleId></ArticleIdList></Reference><Reference><Citation><b>Jones, K. R., Y. M. Joo, S. Jang, Y. J. Yoo, H. S. Lee, I. S. Chung, C. H. Olsen, J. M. Whitmire, D. S. Merrell, and J. H. Cha.</b> 2009. Polymorphism in the CagA EPIYA motif impacts development of gastric cancer. J. Clin. Microbiol. 47<b>:</b>959-968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2668329</ArticleId><ArticleId IdType="pubmed">19158258</ArticleId></ArticleIdList></Reference><Reference><Citation><b>Naito, M., T. Yamazaki, R. Tsutsumi, H. Higashi, K. Onoe, S. Yamazaki, T. Azuma, and M. Hatakeyama.</b> 2006. Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology 130<b>:</b>1181-1190.</Citation><ArticleIdList><ArticleId IdType="pubmed">16618412</ArticleId></ArticleIdList></Reference><Reference><Citation><b>Nogueira, C., C. Figueiredo, F. Carneiro, A. T. Gomes, R. Barreira, P. Figueira, C. Salgado, L. Belo, A. Peixoto, J. C. Bravo, L. E. Bravo, J. L. Realpe, A. P. Plaisier, W. G. Quint, B. Ruiz, P. Correa, and L. J. van Doorn.</b> 2001. Helicobacter pylori genotypes may determine gastric histopathology. Am. J. Pathol. 158<b>:</b>647-654.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1850299</ArticleId><ArticleId IdType="pubmed">11159201</ArticleId></ArticleIdList></Reference><Reference><Citation><b>Nomura, A. M., G. I. Perez-Perez, J. Lee, G. Stemmermann, and M. J. Blaser.</b> 2002. Relation between Helicobacter pylori cagA status and risk of peptic ulcer disease. Am. J. Epidemiol. 155<b>:</b>1054-1059.</Citation><ArticleIdList><ArticleId IdType="pubmed">12034584</ArticleId></ArticleIdList></Reference><Reference><Citation><b>Panayotopoulou, E. G., D. N. Sgouras, K. Papadakos, A. Kalliaropoulos, G. Papatheodoridis, A. F. Mentis, and A. J. Archimandritis.</b> 2007. Strategy to characterize the number and type of repeating EPIYA phosphorylation motifs in the carboxyl terminus of CagA protein in Helicobacter pylori clinical isolates. J. Clin. Microbiol. 45<b>:</b>488-495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1829008</ArticleId><ArticleId IdType="pubmed">17151214</ArticleId></ArticleIdList></Reference><Reference><Citation><b>Rhead, J. L., D. P. Letley, M. Mohammadi, N. Hussein, M. A. Mohagheghi, M. Eshagh Hosseini, and J. C. Atherton.</b> 2007. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 133<b>:</b>926-936.</Citation><ArticleIdList><ArticleId IdType="pubmed">17854597</ArticleId></ArticleIdList></Reference><Reference><Citation><b>Sgouras, D. N., E. G. Panayotopoulou, K. Papadakos, B. Martinez-Gonzalez, A. Roumbani, J. Panayiotou, C. vanVliet-Constantinidou, A. F. Mentis, and E. Roma-Giannikou.</b> 2009. CagA and VacA polymorphisms do not correlate with severity of histopathological lesions in Helicobacter pylori-infected Greek children. J. Clin. Microbiol. 47<b>:</b>2426-2434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2725676</ArticleId><ArticleId IdType="pubmed">19535517</ArticleId></ArticleIdList></Reference><Reference><Citation><b>Soltermann, A., S. Koetzer, F. Eigenmann, and P. Komminoth.</b> 2007. Correlation of Helicobacter pylori virulence genotypes vacA and cagA with histological parameters of gastritis and patient's age. Mod. Pathol. 20<b>:</b>878-883.</Citation><ArticleIdList><ArticleId IdType="pubmed">17541440</ArticleId></ArticleIdList></Reference><Reference><Citation><b>Van Doorn, L. J., C. Figueiredo, F. Megraud, S. Pena, P. Midolo, D. M. Queiroz, F. Carneiro, B. Vanderborght, M. D. Pegado, R. Sanna, W. De Boer, P. M. Schneeberger, P. Correa, E. K. Ng, J. Atherton, M. J. Blaser, and W. G. Quint.</b> 1999. Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology 116<b>:</b>823-830.</Citation><ArticleIdList><ArticleId IdType="pubmed">10092304</ArticleId></ArticleIdList></Reference><Reference><Citation><b>van Doorn, L.-J., C. Figueiredo, R. Sanna, M. J. Blaser, and W. G. Quint.</b> 1999. Distinct variants of Helicobacter pylori cagA are associated with vacA subtypes. J. Clin. Microbiol. 37<b>:</b>2306-2311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC85143</ArticleId><ArticleId IdType="pubmed">10364602</ArticleId></ArticleIdList></Reference><Reference><Citation><b>Yamaoka, Y., T. Kodama, O. Gutierrez, J. G. Kim, K. Kashima, and D. Y. Graham.</b> 1999. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J. Clin. Microbiol. 37<b>:</b>2274-2279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC85136</ArticleId><ArticleId IdType="pubmed">10364597</ArticleId></ArticleIdList></Reference><Reference><Citation><b>Yamaoka, Y., T. Kodama, K. Kashima, D. Y. Graham, and A. R. Sepulveda.</b> 1998. Variants of the 3&#x2032; region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J. Clin. Microbiol. 36<b>:</b>2258-2263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC105028</ArticleId><ArticleId IdType="pubmed">9666002</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>